USD 167.01
(-2.21%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 5.08 USD | 12.64% |
2022 | 4.51 USD | 5.13% |
2021 | 4.29 USD | 24.71% |
2020 | 3.44 USD | 9.55% |
2019 | 3.14 USD | 6.08% |
2018 | 2.96 USD | 68.18% |
2017 | 1.76 USD | 6.02% |
2016 | 1.66 USD | 144.12% |
2015 | 0.68 USD | -41.38% |
2014 | 1.16 USD | 14.85% |
2013 | 1.01 USD | 16.09% |
2012 | 0.87 USD | 70.59% |
2011 | 0.51 USD | 121.74% |
2010 | 0.23 USD | 209.52% |
2009 | -0.21 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 1.31 USD | 14.91% |
2024 Q3 | 1.51 USD | 10.22% |
2024 Q2 | 1.37 USD | 4.58% |
2023 Q1 | 1.19 USD | 20.2% |
2023 Q3 | 1.29 USD | -11.03% |
2023 Q4 | 1.14 USD | -11.63% |
2023 FY | - USD | 12.64% |
2023 Q2 | 1.45 USD | 21.85% |
2022 Q3 | 1.13 USD | 0.0% |
2022 Q4 | 0.99 USD | -12.39% |
2022 Q1 | 1.26 USD | 43.18% |
2022 FY | - USD | 5.13% |
2022 Q2 | 1.13 USD | -10.32% |
2021 Q3 | 1.16 USD | 7.41% |
2021 Q2 | 1.08 USD | -8.47% |
2021 Q1 | 1.18 USD | 57.33% |
2021 FY | - USD | 24.71% |
2021 Q4 | 0.88 USD | -24.14% |
2020 Q3 | 1.01 USD | 27.85% |
2020 FY | - USD | 9.55% |
2020 Q4 | 0.75 USD | -25.74% |
2020 Q1 | 0.89 USD | 9.88% |
2020 Q2 | 0.79 USD | -11.24% |
2019 Q4 | 0.81 USD | -10.99% |
2019 Q3 | 0.91 USD | 18.18% |
2019 FY | - USD | 6.08% |
2019 Q1 | 0.65 USD | -9.72% |
2019 Q2 | 0.77 USD | 18.46% |
2018 Q3 | 0.72 USD | -8.86% |
2018 Q2 | 0.79 USD | 9.72% |
2018 Q1 | 0.72 USD | 323.53% |
2018 FY | - USD | 68.18% |
2018 Q4 | 0.72 USD | 0.0% |
2017 Q4 | 0.17 USD | -72.13% |
2017 Q1 | 0.48 USD | 54.84% |
2017 FY | - USD | 6.02% |
2017 Q2 | 0.50 USD | 4.17% |
2017 Q3 | 0.61 USD | 22.0% |
2016 Q4 | 0.31 USD | -35.42% |
2016 FY | - USD | 144.12% |
2016 Q3 | 0.48 USD | 6.67% |
2016 Q2 | 0.45 USD | 9.76% |
2016 Q1 | 0.41 USD | 925.0% |
2015 FY | - USD | -41.38% |
2015 Q4 | 0.04 USD | -89.47% |
2015 Q3 | 0.38 USD | 613.51% |
2015 Q2 | -0.07 USD | -122.42% |
2015 Q1 | 0.33 USD | 32.0% |
2014 Q2 | 0.27 USD | -12.9% |
2014 Q1 | 0.31 USD | 47.62% |
2014 FY | - USD | 14.85% |
2014 Q4 | 0.25 USD | -24.24% |
2014 Q3 | 0.33 USD | 22.22% |
2013 Q1 | 0.28 USD | 1500.0% |
2013 Q2 | 0.26 USD | -7.14% |
2013 FY | - USD | 16.09% |
2013 Q3 | 0.26 USD | 0.0% |
2013 Q4 | 0.21 USD | -19.23% |
2012 Q2 | 0.36 USD | 56.52% |
2012 Q3 | 0.34 USD | -5.56% |
2012 Q4 | -0.02 USD | -105.88% |
2012 FY | - USD | 70.59% |
2012 Q1 | 0.23 USD | 1177.78% |
2011 Q4 | 0.02 USD | -90.53% |
2011 Q2 | 0.13 USD | -18.75% |
2011 FY | - USD | 121.74% |
2011 Q1 | 0.16 USD | 0.0% |
2011 Q3 | 0.19 USD | 46.15% |
2010 FY | - USD | 209.52% |
2009 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Amneal Pharmaceuticals, Inc. | -0.48 USD | 1158.333% |
Bausch Health Companies Inc. | -1.62 USD | 413.58% |
Catalent, Inc. | -5.76 USD | 188.194% |
Emergent BioSolutions Inc. | -14.85 USD | 134.209% |
Elanco Animal Health Incorporated | -2.50 USD | 303.2% |
Perrigo Company plc | -0.09 USD | 5510.011% |
Teva Pharmaceutical Industries Limited | -0.50 USD | 1116.0% |